Creason v. Department of Health Services

957 P.2d 1323, 76 Cal. Rptr. 2d 489, 18 Cal. 4th 623, 98 Daily Journal DAR 7619, 98 Cal. Daily Op. Serv. 5477, 1998 Cal. LEXIS 4038
CourtCalifornia Supreme Court
DecidedJuly 13, 1998
DocketS063167
StatusPublished
Cited by59 cases

This text of 957 P.2d 1323 (Creason v. Department of Health Services) is published on Counsel Stack Legal Research, covering California Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Creason v. Department of Health Services, 957 P.2d 1323, 76 Cal. Rptr. 2d 489, 18 Cal. 4th 623, 98 Daily Journal DAR 7619, 98 Cal. Daily Op. Serv. 5477, 1998 Cal. LEXIS 4038 (Cal. 1998).

Opinions

[626]*626Opinion

CHIN, J.

Plaintiff Sierra Creason, a minor, and her parents, plaintiffs Claudia and Matthew Creason, sued defendant State of California (acting through the State Department of Health Services (Department)), seeking damages allegedly arising from the state’s failure to diagnose and report timely and accurately that Sierra was suffering from congenital hypothyroidism. The trial court sustained defendant’s demurrer to the first amended complaint without leave to amend and dismissed the action. The Court of Appeal reversed, concluding that plaintiffs adequately stated a cause of action against defendant for failing to diagnose and report Sierra’s test results accurately.

This case presents two issues for our review: (1) whether the newborn screening program contained in the Hereditary Disorders Act (Health & Saf. Code, former § 150 et seq., repealed 1995 [now § 124975 et seq., originally enacted as § 150 et seq. by Stats. 1977, ch. 1037, § 1, p. 3131]) imposed a mandatory duty on the Department to select accurate standards for testing for and reporting possible congenital hypothyroidism, breach of which duty could form the basis for a private cause of action against the state by plaintiffs; and (2) assuming an enforceable mandatory duty existed, whether the state was nonetheless immune from suit under the California Tort Claims Act (see Gov. Code §§ 818.2, 818.4, 820.2, 855.6). As will appear, we conclude (contrary to the opinion of the Court of Appeal in this case) that the state owed plaintiffs no mandatory duty with respect to its development of appropriate testing and reporting procedures, and that, in any event, the state was immune from plaintiffs’ suit.

Facts

The following statement of facts is taken in large part from the Court of Appeal opinion in this case. The first amended complaint contains the following material allegations: Sierra was bom' on October 20, 1990. Shortly after her birth, and as required by state law, a “test specimen” of her blood was taken and sent to a state-contracted laboratory for analysis to determine the existence of certain genetic disorders, including congenital hypothyroidism. According to plaintiffs, “One purpose of such testing is to determine whether a newborn is producing sufficient thyroid hormone to ensure proper growth and development and to permit early medical intervention if necessary.”

[627]*627Plaintiffs further alleged that “Participation ... in the newborn screening and/or testing procedures was mandated under state law,” and the test “was conducted solely by Defendant State and by State contracted or approved entities [f] ... to ensure full public protection against the devastating effects of preventable hereditary disorders and to permit early detection and necessary medical intervention.” According to plaintiffs, “Defendant State was under a mandatory duty to exercise reasonable diligence in the formulation of testing and reporting procedures such that accurate information was made available to parents and physicians of newborns ... in order to achieve the stated purposes” of state law.

Plaintiffs also alleged the testing laboratory, acting under state contract, informed plaintiffs and their physician the test was “negative” for congenital hypothyroidism. Several months later, plaintiffs discovered Sierra did not have a thyroid gland and suffered from congenital hypothyroidism. Plaintiffs alleged defendant breached its duty by failing to exercise reasonable care and diligence “in the formulation of testing and reporting procedures,” resulting in the failure to detect plaintiff Sierra’s congenital hypothyroidism. Although not specifically alleged, plaintiffs’ implicit premise is that if Sierra’s condition had been timely diagnosed, thyroid hormone could have been administered to prevent her injuries.

In addition to the allegations of the first amended complaint, plaintiffs’ original complaint had alleged that on October 20, 1990, Sierra was tested for congenital hypothyroidism, that the test findings showed low counts on both the thyroid stimulating hormone (TSH) component and the thyroxin 4 (T4) component of the test, and that defendant had previously determined that only those tests that resulted in a high TSH factor and a low T4 factor would be reported as “positive” to the child’s parents and pediatrician. According to plaintiffs, defendant knew or should have known that children with a low count on both components of the test “are known to have congenital hypothyroidism . . . .” Plaintiffs charged that defendant “so designed, created, managed, maintained, and operated said testing procedure . . . so as to proximately cause Plaintiff, Sierra Creason’s, congenital hypothyroidism to go undetected until approximately April 23, 1991 . . . .”

As previously stated, those allegations were contained in plaintiffs’ original complaint but were not included in the first amended complaint. Nonetheless, this factual recital may be considered on demurrer despite plaintiffs’ subsequent deletion of it. (See 4 Witkin, Cal. Procedure (4th ed. 1997) Pleading, § 419, pp. 514-515, and cases cited.) Indeed, in their opposition to defendant’s demurrer to the first amended complaint, plaintiffs reaffirm that [628]*628their action is based on the state’s, incorrect and inaccurate “determination that only those tests that resulted in a high TSH factor, and a low T4 factor would be reported as ‘Positive’ for hypothyroidism.”

Based on those allegations in plaintiffs’ pleadings, we may assume the gist of their action accuses defendant of adopting faulty testing standards that fail to report all possible cases of hypothyroidism. In other words, any negligence on defendant’s part occurred not while testing Sierra but earlier, during the formulation of the standards designed for interpreting and reporting the results of the tests ultimately given. The question before us is whether the state had a mandatory duty to require its testing facilities to report the low TSH test values to parents and treating pediatricians as potentially indicative of hypothyroidism, rather than adopting testing standards deeming those values within a “Normal” or “Negative” range.

Plaintiffs also argue that the trial court abused its discretion in sustaining defendant’s demurrer without leave to amend. They assert that, after they filed the first amended complaint, but before the court ruled on the demurrer, they learned additional supporting facts during a 1992 deposition of George Cunningham, M.D., a physician employed by the Department. During his deposition, Dr. Cunningham admitted that the “Negative” test report for plaintiff Sierra inaccurately purported to cover potential “congenital hypothyroidism,” rather than “primary” congenital hypothyroidism, a more limited form of the disease that involves the thyroid gland, and the only disease covered by the test. In plaintiffs’ view, because hypothyroidism can also exist in secondary and tertiary forms (involving either the pituitary or hypothalamus glands), defendant overstated the scope of the test, thereby possibly misleading Sierra’s treating physician into assuming the test was negative as to all three forms of the disease.

Dr. Cunningham, however, also explained at his deposition that the Department previously had formally notified all California doctors treating newborn infants regarding the more restrictive scope of the test, and that these doctors understand that only primary hypothyroidism is reported.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kunau v. Superior Court CA3
California Court of Appeal, 2026
Davallou v. County of Santa Clara CA6
California Court of Appeal, 2025
Holman v. County of Butte
California Court of Appeal, 2025
Holman v. County of Butte CA3
California Court of Appeal, 2025
Jenkins v. Department of Justice CA5
California Court of Appeal, 2025
O'Farrell v. City of San Diego CA4/1
California Court of Appeal, 2024
Valjalo v. Taylor
E.D. California, 2024
Cox v. County of San Joaquin
E.D. California, 2023
Cleveland v. Taft Union High School Dist.
California Court of Appeal, 2022
Rivas v. Los Angeles Housing Authority CA2/1
California Court of Appeal, 2021
City of L.A. v. Super. Ct.
California Court of Appeal, 2021
Wheeler v. Sahni CA4/1
California Court of Appeal, 2021
Richardson v. Dept. of Motor Vehicles
California Court of Appeal, 2018
Richardson v. Dep't of Motor Vehicles
235 Cal. Rptr. 3d 434 (California Court of Appeals, 5th District, 2018)
Towery v. State of California
California Court of Appeal, 2017
Towery v. State
221 Cal. Rptr. 3d 692 (California Court of Appeals, 5th District, 2017)
B.H. v. County of San Bernardino
361 P.3d 319 (California Supreme Court, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
957 P.2d 1323, 76 Cal. Rptr. 2d 489, 18 Cal. 4th 623, 98 Daily Journal DAR 7619, 98 Cal. Daily Op. Serv. 5477, 1998 Cal. LEXIS 4038, Counsel Stack Legal Research, https://law.counselstack.com/opinion/creason-v-department-of-health-services-cal-1998.